Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
Clinical trial NCT05677724 · UNKNOWN
Trial details
- NCT number
- NCT05677724
- Sponsor
- Fubing Wang
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.